METHADONE-MAINTENANCE IN AUSTRALIA

被引:21
作者
CAPLEHORN, JRM
BATEY, RG
机构
[1] Methadone Statistics Unit, New South Wales Department of Health
关键词
D O I
10.1177/002204269202200314
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The history of methadone treatment in Australia has been and continues to be marked by conflict between two competing aims: harm minimisation and abstinence. The two approaches tend to be associated with high dose-long term and low dose-short term treatment, respectively. Most programmes fail to provide adequate ancillary services, often to the detriment of patient outcome. Despite chronic under-funding, a relative lack of staff training and, in some states, the absence of a system of clinical accountability, Australian methadone services have grown significantly in the last decade. Factors influencing the growth of programmes have been described using the New South Wales programme as the example as it represents the largest and most complex programme in the country. Current problems and the impact of the Human Immunodeficiency Virus on policy development are highlighted.
引用
收藏
页码:661 / 678
页数:18
相关论文
共 54 条
  • [1] ALLISON M, 1985, TREATMENT PROCESS ME
  • [2] *AUSTR DEP HLTH, 1985, METH GUID GUID US M
  • [3] *AUSTR NAT HLTH ME, 1977, NAT POL METH
  • [4] BALDWIN R, 1985, CONNEXIONS, V5, P12
  • [5] BALDWIN R, 1983, POLICY USE METHADONE
  • [6] BARTA Z, 1985, CONNEXIONS, V5, P2
  • [7] HEPATITIS-C VIRUS IN INTRAVENOUS-DRUG-USERS
    BELL, J
    BATEY, RG
    FARRELL, GC
    CREWE, EB
    CUNNINGHAM, AL
    BYTH, K
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (05) : 274 - 276
  • [8] BLACKER P, 1986, CONNEXIONS, V6, P4
  • [9] BOLTON M, 1984, AUSTR DRUG ALCOHOL R, V3, P41
  • [10] BUTT L, 1989, CONNEXIONS, V9, P22